Jefferies Financial Group downgraded shares of Rallybio (NASDAQ:RLYB – Free Report) from a buy rating to a hold rating in a research note published on Wednesday morning, Marketbeat Ratings reports. A number of other research analysts also recently issued reports on RLYB. HC Wainwright restated a buy rating and set a $17.00 target price on […]
Rallybio Co. (NASDAQ:RLYB – Free Report) – Equities research analysts at Wedbush issued their FY2028 EPS estimates for shares of Rallybio in a report issued on Tuesday, February 6th. Wedbush analyst L. Chico forecasts that the company will post earnings of ($0.88) per share for the year. Wedbush has a “Outperform” rating and a $13.00 […]
Rallybio (NASDAQ:RLYB – Get Free Report) had its price target reduced by equities researchers at Wedbush from $14.00 to $13.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Wedbush also issued estimates for Rallybio’s FY2028 earnings at ($0.88) EPS. A […]
Shares of Rallybio Co. (NASDAQ:RLYB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month […]
Shares of Rallybio Co. (NASDAQ:RLYB – Get Free Report) shot up 6.2% on Tuesday . The company traded as high as $5.00 and last traded at $4.95. 34,663 shares changed hands during mid-day trading, a decline of 48% from the average session volume of 66,846 shares. The stock had previously closed at $4.66. Wall Street […]